- Home
- EDSA vs ANTE Comparison
EDSA vs ANTE Comparison
Compare EDSA & ANTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- ANTE
- Stock Information
- Founded
- EDSA 2015
- ANTE 2005
- Country
- EDSA Canada
- ANTE China
- Employees
- EDSA N/A
- ANTE N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- ANTE Advertising
- Sector
- EDSA Health Care
- ANTE Consumer Discretionary
- Exchange
- EDSA Nasdaq
- ANTE Nasdaq
- Market Cap
- EDSA 6.1M
- ANTE 5.7M
- IPO Year
- EDSA N/A
- ANTE N/A
- Fundamental
- Price
- EDSA $1.89
- ANTE $0.44
- Analyst Decision
- EDSA Strong Buy
- ANTE
- Analyst Count
- EDSA 1
- ANTE 0
- Target Price
- EDSA $21.00
- ANTE N/A
- AVG Volume (30 Days)
- EDSA 31.2K
- ANTE 110.8K
- Earning Date
- EDSA 02-07-2025
- ANTE 12-26-2024
- Dividend Yield
- EDSA N/A
- ANTE N/A
- EPS Growth
- EDSA N/A
- ANTE N/A
- EPS
- EDSA N/A
- ANTE 2.64
- Revenue
- EDSA N/A
- ANTE $500,000.00
- Revenue This Year
- EDSA N/A
- ANTE N/A
- Revenue Next Year
- EDSA N/A
- ANTE N/A
- P/E Ratio
- EDSA N/A
- ANTE $0.18
- Revenue Growth
- EDSA N/A
- ANTE N/A
- 52 Week Low
- EDSA $1.69
- ANTE $0.26
- 52 Week High
- EDSA $5.99
- ANTE $2.90
- Technical
- Relative Strength Index (RSI)
- EDSA 37.11
- ANTE 47.27
- Support Level
- EDSA $1.73
- ANTE $0.37
- Resistance Level
- EDSA $2.55
- ANTE $0.46
- Average True Range (ATR)
- EDSA 0.18
- ANTE 0.06
- MACD
- EDSA 0.03
- ANTE -0.00
- Stochastic Oscillator
- EDSA 25.58
- ANTE 46.67
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About ANTE AirNet Technology Inc.
AirNet Technology Inc provides in-flight solutions to connectivity, entertainment, and digital multimedia in China. It offers Internet connections through a network of satellites and land-based beacons, provides airline travelers with interactive entertainment, and breaking news, and furnishes corporate clients with advertisements tailored to the perceptions of the travelers. The revenues are mainly derived from selling advertising time slots on the companies advertising networks and cryptocurrency mining.